HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Konstantinos Zervas Selected Research

Tartrate-Resistant Acid Phosphatase

1/2014The combination of lenalidomide and dexamethasone reduces bone resorption in responding patients with relapsed/refractory multiple myeloma but has no effect on bone formation: final results on 205 patients of the Greek myeloma study group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Konstantinos Zervas Research Topics

Disease

10Multiple Myeloma
01/2014 - 09/2004
6Waldenstrom Macroglobulinemia (Macroglobulinemia)
06/2011 - 09/2004
5Anemia
07/2012 - 11/2006
5Neoplasms (Cancer)
12/2009 - 07/2008
2Bone Resorption
01/2014 - 09/2012
2Bone Diseases (Bone Disease)
02/2012 - 03/2009
2Lymphoma (Lymphomas)
12/2009 - 05/2007
2Plasmacytoma
02/2008 - 01/2007
1Hernia (Hernias)
01/2022
1Infections
05/2018
1Monoclonal Gammopathy of Undetermined Significance
09/2012
1Immunoglobulin Light-chain Amyloidosis
02/2010
1Chronic Disease (Chronic Diseases)
12/2009
1Plasma Cell Leukemia
07/2008
1Iron Deficiencies
07/2008
1Neutropenia
08/2007
1Pyoderma Gangrenosum
07/2007
1Thrombocytopenia (Thrombopenia)
11/2006
1Hypoalbuminemia
11/2006

Drug/Important Bio-Agent (IBA)

6Dexamethasone (Maxidex)FDA LinkGeneric
01/2014 - 02/2006
5Bortezomib (Velcade)FDA Link
09/2012 - 02/2008
3Rituximab (Mabthera)FDA Link
06/2011 - 08/2007
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2010 - 03/2009
3IronIBA
12/2009 - 05/2007
3HematinicsIBA
12/2009 - 07/2008
3CreatinineIBA
03/2009 - 11/2006
3Thalidomide (Thalomid)FDA Link
01/2007 - 11/2004
2Alkaline PhosphataseIBA
01/2014 - 09/2012
2collagen type I trimeric cross-linked peptideIBA
01/2014 - 09/2012
2Serum AlbuminIBA
07/2012 - 09/2004
2HepcidinsIBA
12/2009 - 08/2009
1Fluconazole (Zonal)FDA LinkGeneric
05/2018
1Pharmaceutical PreparationsIBA
05/2018
1Metronidazole (Metric)FDA LinkGeneric
05/2018
1Collagen Type I (Type I Collagen)IBA
01/2014
1Tartrate-Resistant Acid PhosphataseIBA
01/2014
1Lenalidomide (CC 5013)FDA Link
01/2014
1OsteocalcinIBA
01/2014
1OsteoprotegerinIBA
01/2014
1CollagenIBA
09/2012
1Angiopoietin-2IBA
02/2012
1CytokinesIBA
02/2012
1Angiopoietin-1IBA
02/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2012
1angiogeninIBA
02/2012
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
02/2012
1NucleosidesIBA
06/2011
1Amyloid (Amyloid Fibrils)IBA
02/2010
1Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
02/2010
1Pamidronate (Aredia)FDA LinkGeneric
11/2009
1Ibandronic Acid (Boniva)FDA Link
11/2009
1Zoledronic Acid (Zometa)FDA Link
11/2009
1Cystatin CIBA
03/2009
1Monoclonal AntibodiesIBA
08/2007
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2007
1Alkylating AgentsIBA
08/2007
1Immunoglobulin G (IgG)IBA
07/2007
1ErythropoietinFDA Link
05/2007
1Melphalan (Alkeran)FDA LinkGeneric
02/2006
1Hemoglobins (Hemoglobin)IBA
09/2004

Therapy/Procedure

1Length of Stay
01/2022
1Therapeutics
02/2012
1Drug Therapy (Chemotherapy)
12/2009